Quick Answer:The Canada Cosmetic Ingredient Hotlist is Health Canada’s administrative tool for communicating prohibited and restricted cosmetic substances. A prohibited entry and a restricted entry require different decisions: restrictions can depend on concentration, product use and warnings. An ingredient’s absence from the Hotlist is not safety approval. Brands need formula-level screening against current entries and a separate assessment of the finished product’s safety and classification.
By mooyam_admin, MOOYAM editorial team. Last reviewed: 12 October 2026. Cover: AI-generated editorial illustration.
What is the Hotlist, and what does it not prove?
Health Canada’s Hotlist policy and reading instructions explain its status. It is not exhaustive, and authorities can act on safety concerns even if a substance has no listed entry. The Food and Drugs Act, section 16, prohibits sale of cosmetics that may injure users under directed or customary use, contain specified objectionable material, or are made, prepared, preserved, packaged or stored under unsanitary conditions. A name search alone cannot establish those broader safety duties.
For a brand owner, the useful question is not “Does this formula have a Hotlist certificate?” It is “Who has reviewed this exact formula, for this intended use, against the current Canadian requirements, and what evidence supports the decision?” Keep the answer in a controlled technical file. For the wider launch pathway, read Health Canada cosmetic requirements.
| Review area | Canadian reference | Do not confuse it with |
|---|---|---|
| Ingredient prohibition/restriction | Health Canada’s current Hotlist entries | A list of every safe ingredient |
| Finished-product safety | Food and Drugs Act, section 16 | A passing name search |
| Notification data | Health Canada’s CNF instructions | Product approval |
How should prohibited, restricted and unmatched entries be handled?
Prohibited entries should not be present in cosmetics sold in Canada, including relevant synonyms and related substances covered by the entry. Restricted entries require the specified use conditions and cautionary statements. The Hotlist concerns intentionally added substances; that does not mean contamination can be ignored. Assign unresolved identity or composition questions to technical review instead of treating an unmatched search as a pass.
| Finding | Review question | Project action |
|---|---|---|
| Prohibited match | Is the substance within the entry’s scope? | Hold formula release; obtain a documented resolution |
| Restricted match | Are all conditions applicable to this product satisfied? | Record calculation, use category and labeling checks |
| No match | Is identity confirmed and the wider safety review complete? | Continue assessment; do not label it approved |
| Uncertain synonym or blend | What is actually present in the supplied raw material? | Request supplier clarification before sign-off |
Why must the whole entry be read?
The current Hotlist tables illustrate why a single concentration number is insufficient. For example, benzethonium chloride is not permitted in products applied to mucous membranes; its limits are 0.2% in leave-on products and 0.3% in rinse-off products. This example is a reading exercise, not a recommendation to use the substance or a conclusion about any specific formulation.
When documenting an entry, keep the substance name, identifiers, applicable category, full conditions and review date together. Do not copy the maximum concentration into an isolated spreadsheet cell and discard the qualifying text. A later reviewer should be able to reproduce the decision without searching through an unrelated supplier email.
How does a brand organize a formula-level screen?
- Define the reviewed product. Record formula version, intended body area, user group, leave-on/rinse-off use, format and proposed claims.
- Obtain complete raw-material information. Request technical composition for blends, preservatives, fragrances and extracts where needed for the review. An attractive trade name is not an adequate substance identifier.
- Resolve identities. Reconcile INCI names, CAS numbers, synonyms and supplier codes. Escalate conflicting documentation rather than choosing the most convenient name.
- Calculate finished-product contributions. Have the formulation team assess contributions across ingredients and retain the calculation basis. Document whether figures refer to a supplied blend or its constituent substance.
- Read current entries in context. Capture relevant conditions and identify whether the proposed use falls within them.
- Connect decisions to artwork and notification. Route any warning or declaration changes to the labeling reviewer; reconcile notification inputs with the reviewed formulation.
- Approve and maintain the record. Name the responsible reviewer, record unresolved questions, and reopen review when a relevant input changes.
This sequence is MOOYAM’s editorial recommendation for a practical handover, not an official prescribed assessment method. A reviewer should adapt it to the product’s risk and the evidence available. Do not assign technical conclusions to marketing staff solely because they can access the online list.
What information is useful for the Cosmetic Notification Form?
Health Canada’s common notification issues guidance recommends exact concentrations for restricted ingredients, which can help processing. It also addresses ingredient identification and concentration data. Prepare these inputs from the controlled formula; do not infer a concentration from a consumer label’s order. Our CNF guide explains the notification workflow separately.
Practical handover control: use the same formula identifier on the screen, supplier composition pack and notification worksheet. If a notifier receives a range while the technical reviewer used an exact percentage, retain the relationship between the two. Avoid disconnected versions that make it unclear what formulation was actually assessed.
What does the manufacturer provide, and what does the brand decide?
Here “manufacturer” refers to the physical factory; Canadian legal definitions may assign responsibilities differently. Agree the project roles before ordering. The factory can provide technical inputs, but a commercial supply agreement does not by itself resolve local statutory obligations.
| Factory / formulation support | Brand / importer coordination |
|---|---|
| Formula-linked INCI data, supplier composition and relevant COA/SDS | Appoint the Canadian compliance reviewer and confirm use/claims |
| Concentration calculations and quality evidence within agreed scope | Resolve market decisions and approve final labeling |
| Change notices for formula or supplier revisions | Maintain the review record and notification workflow |
Common mistakes to catch before release
- Searching only a trade name: obtain substance identities and blend composition.
- Using the wrong product category: confirm actual application and use, not merely the category chosen for marketing.
- Assuming European compliance answers Canada: keep a distinct Canadian assessment.
- Calling an unmatched ingredient approved: record the limited scope of the search and continue safety review.
- Keeping an old label after a formula change: reopen Canadian cosmetic labeling review when relevant inputs change.
FAQ
Is the Hotlist a cosmetic certification?
No. It communicates ingredient prohibitions and restrictions; it is not a third-party certificate or government product approval.
Does “not listed” mean safe?
No. The list is not exhaustive. Finished-product safety and other applicable requirements remain separate questions.
Can a restricted ingredient be used in any cosmetic?
No. The entry’s product-use conditions matter, not only its concentration limit.
Can a brand screen a formula using only its INCI label?
That can be a preliminary check, but technical review may require composition and concentration information not visible on the consumer label.
When should the screening record be reopened?
As a project control, reassess changes to formula, supplier composition, intended use, claims or relevant regulatory information. Document what changed and who reviewed it.
Plan your technical documentation handover
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Discuss formula-linked information, relevant quality records and change-control expectations through our OEM/ODM service or contact team. Product-specific Canadian compliance conclusions should be verified by the appropriate qualified reviewer.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.